---
title: AARS_Internal_Validation_Loop_02_Risk_Note
type: risk-object
status: draft
project: Proj_002_AARS_Internal_Validation
tags:
  - aars
  - internal-validation
  - loop-02
  - risk
created: 2026-03-28
source: ChatGPT
risk_id: Internal_Validation_Loop_02_RISK_01
domain: AARS
linked_case: Internal_Validation_Loop_02
linked_project: Proj_002_AARS_Internal_Validation
---

# AARS_Internal_Validation_Loop_02_Risk_Note

## 1. Risk Identity

**Risk ID:** Internal_Validation_Loop_02_RISK_01  
**Project:** Proj_002_AARS_Internal_Validation  
**Case:** Internal_Validation_Loop_02  
**Domain:** AARS  
**Current Status:** reviewable  

---

## 2. Risk Statement

There is a risk that the internal validation project may produce a project-level latest stable view that appears coherent, but is under-supported because the underlying review evidence is still too narrow or too weak.

---

## 3. Origin

The risk originates from the dependency that:
- stable-view quality depends on review quality
- current validation evidence still comes from a small number of bounded loops
- the project is still close to the original AARS system context

---

## 4. Pathway

The pathway is:

weak or narrow review evidence  
→ overconfident stable-view acceptance  
→ continuation from a not-yet-strong-enough anchor  
→ inflated production-readiness confidence

---

## 5. Bounded Consequence

The main bounded consequence is:

the internal validation project may overstate how much repeatability has been proven, which could weaken Round_02 judgment quality.

---

## 6. Evidence Note

- Loop_01 proved that a second bounded project context can be opened and reviewed  
- Loop_02 is now testing deeper object-chain logic, but still in a limited internal context  
- the validation project is useful, but not yet broad enough for strong cross-context certainty  

---

## 7. Unresolved Items

- how much review depth is enough before stable-view confidence should increase materially  
- whether a later external or more contrastive context is still needed  
- whether the current internal validation context is sufficient for stronger production-readiness claims  

---

## 8. Current Judgment

**reviewable / conditionally stable risk**

Interpretation:
- the risk is explicit and bounded
- it is meaningful enough to carry forward
- but still needs downstream health judgment rather than immediate escalation

---

## 9. Review Questions

1. Is the risk clearly bounded?
2. Is the origin visible?
3. Is the pathway explicit enough?
4. Is the consequence domain bounded?
5. Is false precision avoided?
6. Is the evidence adequate for the current status?

---

## 10. Recommended Next Step

Create:

```text
AARS_Internal_Validation_Loop_02_Health_Snapshot.md